Safety assessment of obinutuzumab: Real-world adverse event analysis based on the FAERS and JADER databases from 2013 to 2025

• Xiangpeng Li,

  Roles Conceptualization, Writing – original draft

  Affiliation Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

  ⨯
• Haonan Liang,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Pharmacy, The People’s Hospital of Rongcheng, Weihai, Shandong, China

  ⨯
• Ping Leng,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

  ⨯
• Zhanqi Cao

  Roles Data curation, Writing – original draft, Writing – review & editing

  * E-mail: czq0803@qdu.edu.cn

  Affiliation Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

  https://orcid.org/0000-0002-1576-5167

  ⨯